1/27/2026Boehringer Ingelheim Strikes €1.05B Deal With Simcere for Preclinical...

1/26/2026Neowise Raises Over CNY 200M in Series B to Advance TCR-T Therapies fo...

1/26/2026HealZen Unveils Global Strategic Partnership to Advance Degrader-Antib...

1/26/2026Dizal Pharma's Hong Kong IPO Application Accepted

1/23/2026China Grants Conditional Approval to First Hepatitis D Treatment

1/23/2026Fosun Pharma Moves to Spin Off Vaccine Unit for Hong Kong IPO

1/23/2026Livzon Moves to Acquire Majority Stake in Vietnam's Imexpharm

1/23/2026Gene Key Secures Over CNY 100M to Accelerate iNKT Cell Therapy Develop...

1/22/2026Hua Medicine Targets Global Diabetes Growth with Non-GLP-1 Strategy

1/22/2026Corxel Raises Up to $287M to Push GLP-1 Pill Toward Global Markets

1/22/2026Bangshun Pharma Files for Hong Kong IPO

1/22/2026T-MAXIMUM Unveils First Human Data for CRISPR-Edited CAR-T

1/21/2026Pomdoctor Deepens Pharma Partnerships to Drive Internet Hospital Expan...

1/21/2026NewDEL Raises A+ Round Led by XtalPi to Accelerate DEL-AI Drug Develop...

1/21/2026Harbour BioMed Takes Strategic Stake in Spruce Biosciences

1/20/2026Ellipses In-Licenses First-in-Class B7H3 ADC from China's Innolake

1/20/2026Insilico and Hygtia Therapeutics Forge Global Alliance on AI-Discovere...

1/20/2026GSK to Buy RAPT Thera for $2.2B, Securing China-Partnered Anti-IgE Ass...

1/19/2026Biyo Secures ~CNY 100M in Pre-A Funding as Lead Migraine Biologic Adva...

1/19/2026ABM Thera Licenses MEK1/2 Inhibitor ABM-168 to Mosaica Medicines for G...

1/19/2026Henlius Biotech Secures Global Rights to IL-1RAP Antibody from U-mab B...

1/19/2026AstraZeneca Acquires Full Global Rights to AbelZeta’s GPC3 Armored CA...

1/16/2026AmCham China Survey Shows Resilience and Improving Performance Among U...

1/16/2026HEC Pharma Wins China Approval for Olorigliflozin in Type 2 Diabetes

1/16/2026WuXi Biologics and WuXi XDC Launch HK$1.86B Takeover Bid for BioDLink

1/16/2026Exegenesis Files for HKSE IPO to Advance Gene and Oligonucleotide Ther...

1/16/2026Zenitar Files for HKSE IPO Following $87M Series C Raise

1/16/2026Simcere Zaiming Files for Hong Kong IPO to Accelerate Oncology Pipelin...

1/14/2026Caldera Launches with $112.5 Million to Advance China-Licensed IBD Bs...

1/14/2026Sino Biopharma Completes Full Acquisition of Hygieia for CNY 1.2B

Page:3/25 Total number of articles:746: [First][<<] [1] [2] [3] [4] [5] [>>] [End]